Related references
Note: Only part of the references are listed.Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain
Wolfgang Schroeder et al.
EUROPEAN JOURNAL OF PAIN (2010)
Tapentadol immediate release for the relief of moderate-to-severe acute pain
Craig T. Hartrick
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Preclinical and Early Clinical Investigations Related to Monoaminergic Pain Modulation
Kirsty Bannister et al.
NEUROTHERAPEUTICS (2009)
(-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (Tapentadol HCl):: a novel μ-opioid receptor agonist norepinephrine Reuptake inhibitor with broad-spectrum analgesic properties
Thomas M. Tzschentke et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Tapentadol hydrochloride. Analgesic, Mu-opioid receptor agonist, noradrenaline reuptake inhibitor.
T. M. Tzschentke et al.
DRUGS OF THE FUTURE (2006)
Opiclids in neuropathic pain
R Przewlocki et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Share Paper
